Switching to rIX-FP prophylaxis at dosing intervals of up to 14 days in a hemophilia B pediatric patient decreased treatment burden by reducing the number of administrations and hospital visits, without affecting efficacy or treatment adherence. This is particularly important in contexts of limited mobility and overloaded healthcare services.
Keywords: hemophilia B; pediatrics; prophylaxis; rIX‐FP.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.